CHAN LY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner OLYMPIA, WA NPI 1932736121
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner WA Acerta Pharma LLC All categories
General Payments — all program years on this page
$2,789.00
- Category: General Payments
- Program years: PY2023–2024
- Record count: 49
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,828.87 across 39 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,828.87 | 39 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $246.67 | 6 |
| EISAI INC. | $240.68 | 2 |
| Janssen Biotech, Inc. | $236.41 | 6 |
| SOBI, INC | $210.75 | 2 |
| ABBVIE INC. | $122.82 | 1 |
| Janssen Scientific Affairs, LLC | $114.30 | 1 |
| Agios Pharmaceuticals, Inc. | $93.53 | 1 |
| Tempus AI, Inc | $91.60 | 1 |
| Merck Sharp & Dohme Corporation | $74.42 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $58.04 | 2 |
| Stemline Therapeutics Inc. | $55.02 | 2 |
| Celgene Corporation | $34.80 | 1 |
| BeiGene USA, Inc. | $31.59 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.88 | 1 |
| Lilly USA, LLC | $25.15 | 1 |
| Incyte Corporation | $25.09 | 1 |
| Ipsen Biopharmaceuticals, Inc | $23.60 | 1 |
| ACCORD HEALTHCARE, INC. | $22.58 | 1 |
| Daiichi Sankyo Inc. | $20.73 | 1 |
| GlaxoSmithKline, LLC. | $20.63 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $17.93 | 1 |
| TOLMAR, INC. | $17.25 | 1 |
| Azurity Pharmaceuticals, Inc. | $16.40 | 1 |
By program year
Records — PY2024 (39)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.